cjc1295 ipamorelin peptide research CJC-1295 / Blend CJC-1295 with Ipamorelin Peptide
Description
10.1152/physrev.00047.2006 81 HuttnerA
The product is formulated strictly for research use only and intended for controlled laboratory environments
If secondary cleavage sites exist, re-clone into a different vector
Because cancer cells hijack the protective capability of NRF2 to promote drug resistance and proliferation, specific NRF2 inhibitors would be desirable for the treatment of cancers that have constitutively active NRF2
